$12.93+0.21 (+1.65%)
DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. in the Healthcare sector is trading at $12.93 with a market capitalization of $2.1B. Wall Street consensus targets $13.38 (16 analysts), implying a +3.4% move over the next 12 months. The stock is currently 21% below its 52-week high of $16.29, remaining 10.3% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $880.00M↓ | $961.00M↑ | $904.00M↓ | $936.00M↑ | $879.00M |
| Gross Profit | $427.00M↓ | $443.00M↑ | $441.00M↓ | $490.00M↑ | $466.00M |
| Operating Income | $30.00M↑ | $25.00M↓ | $46.00M↓ | $110.00M↑ | $70.00M |
| Net Income | -$10.00M↑ | -$146.00M↑ | -$427.00M↓ | -$45.00M↓ | $20.00M |
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Tech...
Dentsply Sirona has been treading water for the past six months, recording a small loss of 0.5% while holding steady at $12.66. The stock also fell short of the S&P 500’s 7.9% gain during that period.
We recently published Jim Cramer’s Biggest Losers: 10 Stocks That Just Didn’t Work Out. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is one of the stocks discussed by Jim Cramer. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is a dental products manufacturer. Its shares are down by 26.9% over the past year and are up by 3.4% year-to-date. Soon after Cramer […]
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Dentsply Sirona (NASDAQ:XRAY) and its peers.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
DENTSPLY SIRONA has appointed John C. Fortson as Executive Vice President and Chief Financial Officer, effective July 20, 2026, bringing decades of experience in executive finance roles across industrial and materials companies and a background in investment banking and military service. This hire introduces a finance leader with prior CEO and CFO experience in complex, global manufacturing businesses, which may influence how DENTSPLY SIRONA approaches capital allocation, operational...